Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early lumbar cistern drainage plus urokinase for intraventricular hemorrhage
ChiCTR2600123877Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nanchang University
- Start
- Apr 2026
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of urokinase in Intraventricular hemorrhage (IVH) (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: Proportion of patients with mRS 0–3 at 180 days. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
urokinase
03
Conditions
Intraventricular hemorrhage (IVH)
Beyond the preview
Go deeper on ChiCTR2600123877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123877.